Cited by 3Gestational Diabetes Research and ManagementVitamin D Research StudiesPregnancy and Medication Impact

Effect of Vitamin D Supplementation on Glycemic Control, Insulin Sensitivity, and Pregnancy Outcomes in Gestational Diabetes Patients Undergoing Dietary Therapy

Open access
Yu, Shiwen, Yu, Xiaolin, Li, Furong·2025·Journal of Health, Population and Nutrition

Abstract

OBJECTIVE: This study aims to evaluate the effects of vitamin D supplementation on glycemic control, insulin sensitivity, and pregnancy outcomes in patients with gestational diabetes mellitus (GDM) undergoing dietary therapy. METHODS: This is a retrospective cohort study that included 98 patients diagnosed with GDM according to the IADPSG criteria. Patients were divided into two groups based on vitamin D supplementation: the Vitamin D group (n = 49) and the Control group (n = 49). The Vitamin D group received 400 IU of vitamin D daily until delivery. All patients followed a standardized dietary management plan. The primary outcome was the time to achieve glycemic control. Secondary outcomes included changes in HbA1c, HOMA-IR, LDL-C, hs-CRP, MDA, and pregnancy and neonatal outcomes. Propensity score matching (PSM) was used to adjust for baseline differences, and statistical analyses were performed using SPSS version 28.0. RESULTS: A total of 98 patients (49 per group) were included after propensity score matching (PSM), with similar baseline characteristics between groups (all P > 0.05), except for higher gestational edema scores in the control group (P = 0.001). The Vitamin D group achieved glycemic control faster than the control group (adjusted HR = 2.30, 95% CI 1.50-3.52, P < 0.001) and required less insulin (β = -0.11 U/kg/day, 95% CI -0.14 to -0.08, P < 0.001). Significant improvements were observed in key metabolic and inflammatory markers, including HbA1c, fasting blood glucose, 2-hour postprandial glucose, HOMA-IR, LDL-C, hs-CRP, MDA, BMI, and gestational edema score (all P < 0.001), with no change in mid-upper arm circumference. The Vitamin D group also had significantly lower risks of pregnancy complications, adverse outcomes, and neonatal issues (P < 0.05), including reduced rates of pregnancy-induced hypertension, fetal distress, and postpartum hemorrhage. CONCLUSION: Vitamin D supplementation significantly improves glycemic control, enhances insulin sensitivity, and positively impacts pregnancy outcomes in patients with gestational diabetes. Vitamin D supplementation should be considered in the management of GDM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s41043-025-00969-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Emerging clinical evidence indicates that supplementation with vitamin D can improve insulin sensitivity and glucose tolerance in women with GDM, likely by modulating insulin signaling pathways via the VDR and reducing inflammation.

    “Emerging clinical evidence indicates that supplementation with vitamin D can improve insulin sensitivity and glucose tolerance in women with GDM, likely by modulating insulin signaling pathways via the VDR and reducing inflammation [149].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. [1]Juan J, Yang H. Prevalence, prevention, and lifestyle intervention of gestational diabetes mellitus in China. Int J Environ Res Public Health, 2020;17(24). PMC7766930 33353136
  2. [2]Chatzakis C, Cavoretto P, Sotiriadis A. Gestational diabetes mellitus Pharmacological prevention and treatment. Curr Pharm Des. 2021;27(36):3833–40. 33550962 · DOI
  3. [3]Lende M, Rijhsinghani A. Gestational diabetes: overview with emphasis on medical management. Int J Environ Res Public Health, 2020;17(24). PMC7767324 33371325
  4. [4]Mistry SK, et al. Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South asia: A systematic review. Endocrinol Diabetes Metab. 2021;4(4):e00285. 34505412 PMC8502223 · DOI
  5. [6]Agüero-Domenech N et al. Vitamin D deficiency and gestational diabetes mellitus in relation to body mass index. Nutrients, 2021;14(1). PMC8746839 35010982
  6. [7]Bai Y et al. Vitamin D and gestational diabetes mellitus in the IEU OpenGWAS project: A Two-Sample bidirectional Mendelian randomization study. Nutrients, 2024. 16(17). PMC11397161 39275154
  7. [8]Cagiran FT, Kali Z. Role of vitamin D on gestational hypertension, diabetes mellitus, timing and mode of delivery. Eur Rev Med Pharmacol Sci. 2023;27(2):511–6. 36734709
  8. [9]Fernando M et al. Vitamin D-Binding protein in pregnancy and reproductive health. Nutrients, 2020. 12(5). PMC7285222 32443760
  9. [10]Wang L, et al. Serum vitamin D deficiency and risk of gestational diabetes mellitus: a meta-analysis. Arch Med Sci. 2020;16(4):742–51. 32542074 PMC7286344 · DOI
  10. [11]Griffith RJ, et al. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2020;6(6):Cd012394. 32526091 PMC7388385
  11. [12]Gu S, Chen X, Liu Y, Vitamin D. Prevents gestational diabetes mellitus via modulating glucose metabolism in a mouse model. Physiol Res. 2024;73(4):609–19. 39264081 PMC11414587
  12. [13]Ismail NA, Mohamed NA, Ismail, Bador KM. Vitamin D in gestational diabetes mellitus and its association with hyperglycaemia, insulin sensitivity and other factors. J Obstet Gynaecol. 2021;41(6):899–903. 33962550 · DOI
  13. [14]Waters TP, et al. Maternal and neonatal morbidity for women who would be added to the diagnosis of GDM using IADPSG criteria: A secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care. 2016;39(12):2204–10. 27634392 PMC5127228 · DOI · Paper page
  14. [15]Sweeting A, et al. A clinical update on gestational diabetes mellitus. Endocr Rev. 2022;43(5):763–93. 35041752 PMC9512153 · DOI · Paper page
  15. [16]Vince K, Perković P, Matijević R. What is known and what remains unresolved regarding gestational diabetes mellitus (GDM). J Perinat Med. 2020;48(8):757–63. 32827397 · DOI
  16. [19]Li DY, et al. Maternal vitamin D status and risk of gestational diabetes mellitus in twin pregnancies: a longitudinal twin pregnancies birth cohort study. Nutr J. 2024;23(1):41. 38594739 PMC11005156 · DOI
  17. [20]Magnusdottir KS et al. Vitamin D status and association with gestational diabetes mellitus in a pregnant cohort in Iceland. Food Nutr Res, 2021. 65. PMC8009083 33841065
  18. [21]Qiu Y et al. 25-Hydroxyvitamin D, vitamin D binding protein and gestational diabetes mellitus: A Two-Sample Mendelian randomization study. Nutrients, 2024;16(16). PMC11356852 39203740
  19. [23]Aziz F, Khan MF, Moiz A. Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia. Sci Rep. 2024;14(1):6182. 10.1038/s41598-024-56790-z. PMID: 38486097; PMCID: PMC10940289. 38486097 PMC10940289 · DOI
  20. [25]Zhang L, Wang W, Gong J, Wang X, Liang J, Gu S, Su M, Bi S, Sun M, Chen J, Zheng W, Wu J, Wang Z, Liu J, Li H, Chen D, Du L. Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia. J Hypertens. 2024;42(2):236–43. Epub 2023 Sep 29. PMID: 37796172. 37796172 · DOI
  21. [26]Shang M, Zhao N. Early pregnancy vitamin D insufficiency and gestational diabetes mellitus. J Obstet Gynaecol Res. 2022;48(9):2353–62. 35830973 · DOI
  22. [27]Wu C, Song Y, Wang X. Vitamin D supplementation for the outcomes of patients with gestational diabetes mellitus and neonates: A Meta-Analysis and systematic review. Int J Clin Pract. 2023;2023:p1907222. PMC9867594 36713951 · DOI
  23. [28]Zeng Q, et al. Association of vitamin D receptor gene rs739837 polymorphism with type 2 diabetes and gestational diabetes mellitus susceptibility: a systematic review and meta-analysis. Eur J Med Res. 2022;27(1):65. 35526059 PMC9080160 · DOI
  24. [29]Zhang P, Hu X, Jin Y. Causal association between vitamin D and gestational diabetes mellitus: a two-sample Mendelian randomization study. J Matern Fetal Neonatal Med. 2024;37(1):2427760. 39551531 · DOI
  25. [30]Zhang T, et al. Vitamin D on the susceptibility of gestational diabetes mellitus: a mini-review. Front Nutr. 2025;12:1514148. 39963668 PMC11830623 · DOI
  26. [31]Jiang L, et al. Omega-3 fatty acids plus vitamin for women with gestational diabetes or prediabetes: a meta-analysis of randomized controlled studies. J Matern Fetal Neonatal Med. 2022;35(16):3135–42. 32967476 · DOI · Paper page
  27. [32]Wang MM, et al. [Effects of vitamin D supplementation on serum lipid profiles and neonatal outcomes in gestational diabetes mellitus:a Meta-analysis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43(1):82–91. 33663668
  28. [33]Peña-Montero N et al. Differences in DNA methylation in genes involved in vitamin D metabolism are related to insulin requirement in pregnant women with gestational diabetes mellitus. Int J Mol Sci, 2024;25(19). PMC11476386 39408904

Cited by

Sorted by citations

Authors
Yu, S., Yu, X., & Li, F.
Affiliations
Wuxi People's Hospital (CN)
Corresponding author
Li, Furong
Venue
Journal of Health, Population and Nutrition
Published
2025-06-12
Volume
44
Issue
1
Pages
194-194
ISSN
  • 1606-0997 (ISSN-L)
  • 2072-1315
OpenAlex
W4411250091
Cited by
3
References
5
Citations by year
2026: 2 · 2025: 1
FWCI
3.51
Type
journal article
Language
en
Open access
Locations
  • Journal of Health Population and Nutrition (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Vitamin D Research Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, glycemic control, insulin sensitivity, HOMA-IR, dietary therapy, pregnancy outcomes, neonatal outcomes, gestational hypertension, fetal distress, postpartum hemorrhage, oxidative stress, inflammation, HbA1c
MeSH terms
Glycemic Control, Adult, Blood Glucose, Female, Glycated Hemoglobin, Humans, Insulin Resistance, Pregnancy, Pregnancy Outcome, Retrospective Studies, Vitamin D, Diabetes, Gestational, Dietary Supplements, Propensity Score

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review